IP Library Granted Patent US 10,934,628
Granted Patent B2
US 10,934,628 · App. 16/167,384 · Granted Mar 2, 2021

Electrochemical flow-cell for hydrogen production and nicotinamide dependent target reduction, and related methods and systems

Inventors: Paul D. Hoeprich, Jr. (Pleasanton, CA); Sangil Kim (Pleasanton, CA)
Assignee: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
C25B13/08C25B1/02C25B3/04C25B9/00C25B11/0442C25B13/02C25B15/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,934,628
App. No.
16/167,384
Granted
Mar 2, 2021
Kind
B2
Abstract

Methods and systems for hydrogen production or production of a reduced target molecule are described, wherein a nicotinamide co-factor dependent membrane hydrogenase or a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein adsorbed onto an electrically conductive supporting structure, which can preferably be chemically inert, is contacted with protons or a target molecule to be reduced and nicotinamide cofactors in presence of an electric current and one or more electrically driven redox mediators. Methods and systems for production of hydrogen or a reduced target molecule are also described wherein a membrane-bound hydrogenase enzyme or enzyme capable or reducing a target molecule is contacted with protons or the target molecule, a nicotinamide co-factor and a nicotinamide co-factor dependent membrane hydrogenase presented on a nanolipoprotein particle for a time and under condition to allow hydrogen production or production of a reduced target molecule in presence of an electrical current and of an electrically driven redox mediator.

Claims (47)

1. A system for hydrogen production, the system comprising: nanolipoprotein particles presenting a nicotinamide co-factor dependent membrane enzyme, at least two opposing electrodes, comprising a first electrode and a second electrode opposing the first electrode, and an electrically conductive supporting structure between said first electrode and said second electrode, wherein the nanolipoprotein particles are immobilized to the electrically conductive supporting structure and wherein the nanolipoprotein particles, the at least two opposing electrodes and the electrically conductive supporting structure are in a configuration adapted to produce a product from an enzyme-mediated biological reduction reaction.

2. The system according to claim 1 , the system further comprising: a voltage generator, connected to the first and second electrodes.

3. The system according to claim 2 , wherein the voltage generator is configured to create an electric potential of 500 mV between the first and second electrodes.

4. The system according to claim 1 , further comprising an ion exchange membrane between the electrically conductive supporting structure and the second electrode.

5. The system according to claim 1 , wherein the electrically conductive supporting structure is chemically inert.

6. The system according to claim 1 , wherein the electrically conductive supporting structure is an electrically conductive porous supporting structure.

7. The system according to claim 6 , wherein the electrically conductive porous supporting structure comprises graphite beads having a diameter less than or equal to 400 μm.

8. The system according to claim 6 , wherein the electrically conductive porous supporting structure is a mesoporous structure.

9. The system according to claim 8 , wherein the mesoporous structure comprises a three-dimensional mesoporous carbon network structure.

10. The system according to claim 9 , wherein the mesoporous structure further comprises graphitic carbon material.

11. The system according to claim 8 , wherein the mesoporous structure is a graphitic carbon aerogel.

12. The system according to claim 1 , further comprising an oxygen removal system configured to remove dissolved oxygen from a buffer solution containing reagents and flowing through the system.

13. The system according to claim 12 , wherein the oxygen removal system comprises an argon gas bubbler.

14. A method comprising: combining protons, a nicotinamide co-factor and the nicotinamide co-factor dependent membrane enzyme presented on the nanolipoprotein particles immobilized on the electrically conductive supporting structure for a time and under condition to allow production of the product of the enzyme-mediated biological reduction reaction in presence of an electrical current and of an electrically driven redox mediator, the combining performed in the system of claim 1 .

15. The method of claim 14 , wherein the nicotinamide co-factor dependent membrane enzyme is one of malate dehydrogenase, succinate dehydrogenase, lactate dehydrogenase, formate dehydrogenase, L-lactate dehydrogenase, and proline dehydrogenase.

16. The method according to claim 14 , wherein the electrically driven redox mediator comprises a metallic redox mediator.

17. The method according to claim 14 , wherein the combining is performed by contacting a solution comprising the protons, the nicotinamide co-factor and the electrically driven/recycled redox mediator with the electrically conductive supporting structure in presence of the electric current.

18. The method according to claim 14 , wherein the electric current is less than 10 milliamps.

19. A system comprising:

a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein particle; and

an electrochemical flow cell comprising a first electrode and a second electrode, an electrically conductive supporting structure

wherein the electrochemical flow cell is configured to receive a solution in a space between the first electrode and the second electrode, and

wherein the electrically conductive supporting structure is configured to immobilize the nicotinamide co-factor dependent membrane enzyme presented on the nanolipoprotein particle and to be exposed to the solution in the electrochemical flow cell in a configuration adapted to produce a product from an enzyme-mediated biological reduction reaction.

20. The system according to claim 19 , wherein the electrochemical flow cell comprises the nanolipoprotein particles herein described immobilized on the electrically conductive supporting structure.

21. The system according to claim 19 , wherein the electrochemical flow cell further comprises an ion exchange membrane between said first and second electrodes.

22. A method comprising:

providing a solution containing protons, nicotinamide co-factors and one or more electrically driven redox mediators into the electrochemical flow cell of the system of claim 19 ; and

applying a voltage across the first electrode and the second electrode of the electrochemical flow cell.

23. The method according to claim 21 , further comprising capturing the product generated in the electrochemical flow cell.

24. The method according to claim 20 , further comprising removing dissolved oxygen from the solution prior to the providing the solution through the electrochemical flow cell.

25. A method comprising: contacting protons, a nicotinamide co-factor and the nicotinamide co-factor dependent membrane enzyme presented on the nanolipoprotein particle for a time and under condition to allow production of the product from the enzyme-mediated biological reduction reaction in presence of an electrical current and of an electrically driven redox mediator, the contacting performed in the system of claim 19 .

26. The method according to claim 25 , wherein the electrically driven redox mediator is a metallic electrically recycled redox mediator.

27. The method according to claim 26 , wherein the electrically recycled redox mediator is (pentamethylcyclopentadienyl-2,2′ bipyridine hydrogen) rhodium (I).

28. The method according to claim 25 , wherein the nicotinamide co-factor is nicotinamide adenine dinucleotide phosphate.

29. The method according to claim 25 , wherein the nicotinamide co-factor dependent membrane enzyme is one of malate dehydrogenase, succinate dehydrogenase, lactate dehydrogenase, formate dehydrogenase, L-lactate dehydrogenase, and proline dehydrogenase.

30. A system comprising:

a nicotinamide co-factor,

a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein particle,

at least two opposing electrodes for providing an electric current, and

an electrically driven redox mediator for simultaneous combined or sequential use together with the at least two opposing electrodes configured to provide electrons to the nicotinamide co-factor,

wherein the nicotinamide co-factor dependent membrane enzyme is immobilized on an electrically conductive structure and

wherein the nicotinamide co-factor, the nicotinamide co-factor dependent membrane enzyme and electrically driven redox mediator are in a configuration adapted to produce a product from an enzyme-mediated biological reduction reaction.

31. The system according to claim 30 , wherein the electrically driven redox mediator is a metallic electrically recycled redox mediator.

32. The system according to claim 31 , wherein the electrically recycled redox mediator is (pentamethylcyclopentadienyl-2,2′-bipyridine hydrogen) rhodium (I).

33. The system according to claim 31 , wherein the nicotinamide co-factor is nicotinamide adenine dinucleotide phosphate.

34. The system according to claim 33 , wherein the nicotinamide co-factor dependent membrane enzyme is one of malate dehydrogenase, succinate dehydrogenase, lactate dehydrogenase, formate dehydrogenase, L-lactate dehydrogenase, and proline dehydrogenase.

35. The system of claim 30 , further comprising a conduit and at least one pump configured to recycle a buffer solution over the electrically conductive supporting structure.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 28, 2019
From: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 048154/0478 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2018
From: HOEPRICH, PAUL D.; KIM, SANGIL
To: LAWRENCE LIVERMORE NATIONAL SECURITY, LLC
Reel/Frame 047325/0506 →
Continuity (3)
Continuation 14861750 · Sep 22, 2015
Provisional Application 62053659 · Sep 22, 2014
Related Publication 20190055658A1 · Feb 21, 2019
Cited By (1)
US 12,226,529